Celsion Corporation - All News Releaseshttp://investor.celsion.com/releases.cfm?sh_auth=1336701426.0.0.e4da11e5ea1f0ac27ae38dd9d848458ben-usShareholder.com RSS FeedCelsion's ThermoDox® HEAT Study Findings Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO)http://investor.celsion.com/releasedetail.cfm?ReleaseID=765703Fri, 17 May 2013 12:00:00 GMThttp://investor.celsion.com/releasedetail.cfm?ReleaseID=765703Celsion's ThermoDox® HEAT Study Findings Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO)Celsion Corporation Reports First Quarter 2013 Financial Results and Provides Business Updatehttp://investor.celsion.com/releasedetail.cfm?ReleaseID=763472Thu, 09 May 2013 12:00:00 GMThttp://investor.celsion.com/releasedetail.cfm?ReleaseID=763472Celsion Corporation Reports First Quarter 2013 Financial Results and Provides Business UpdateCelsion Announces ThermoDox® HEAT Study Findings to be Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO) in New York City on May 16, 2013http://investor.celsion.com/releasedetail.cfm?ReleaseID=760863Wed, 01 May 2013 12:00:00 GMThttp://investor.celsion.com/releasedetail.cfm?ReleaseID=760863Celsion Announces ThermoDox® HEAT Study Findings to be Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO) in New York City on May 16, 2013Celsion Corporation to Hold First Quarter 2013 Financial Results Conference Call on Thursday, May 9, 2013http://investor.celsion.com/releasedetail.cfm?ReleaseID=760862Wed, 01 May 2013 12:00:00 GMThttp://investor.celsion.com/releasedetail.cfm?ReleaseID=760862Celsion Corporation to Hold First Quarter 2013 Financial Results Conference Call on Thursday, May 9, 2013Celsion Corporation Provides Business Updatehttp://investor.celsion.com/releasedetail.cfm?ReleaseID=758390Tue, 23 Apr 2013 12:00:00 GMThttp://investor.celsion.com/releasedetail.cfm?ReleaseID=758390Celsion Corporation Provides Business UpdateCelsion Corporation Reports Year End 2012 Financial Results and Provides Business Updatehttp://investor.celsion.com/releasedetail.cfm?ReleaseID=749080Mon, 18 Mar 2013 12:00:00 GMThttp://investor.celsion.com/releasedetail.cfm?ReleaseID=749080Celsion Corporation Reports Year End 2012 Financial Results and Provides Business UpdateCelsion Corporation to Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013http://investor.celsion.com/releasedetail.cfm?ReleaseID=747421Tue, 12 Mar 2013 12:00:00 GMThttp://investor.celsion.com/releasedetail.cfm?ReleaseID=747421Celsion Corporation to Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013Celsion Corporation Announces $15 Million Registered Direct Offeringhttp://investor.celsion.com/releasedetail.cfm?ReleaseID=742452Fri, 22 Feb 2013 14:15:00 GMThttp://investor.celsion.com/releasedetail.cfm?ReleaseID=742452Celsion Corporation Announces $15 Million Registered Direct OfferingCelsion Corporation Provides an Update Regarding ThermoDox® Agreements with Zhejiang HISUN Pharmaceutical Company for Chinahttp://investor.celsion.com/releasedetail.cfm?ReleaseID=738150Tue, 05 Feb 2013 23:30:00 GMThttp://investor.celsion.com/releasedetail.cfm?ReleaseID=738150Celsion Corporation Provides an Update Regarding ThermoDox® Agreements with Zhejiang HISUN Pharmaceutical Company for ChinaCelsion Announces Results of Phase III HEAT Study of ThermoDox® in Primary Liver Cancerhttp://investor.celsion.com/releasedetail.cfm?ReleaseID=737033Thu, 31 Jan 2013 12:00:00 GMThttp://investor.celsion.com/releasedetail.cfm?ReleaseID=737033Celsion Announces Results of Phase III HEAT Study of ThermoDox® in Primary Liver Cancer